Cargando…
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
Two biallelic polymorphisms in introns 3 and 6 of the p53 gene were analysed for a possible risk-modifying effect for ovarian cancer. Germline DNA was genotyped from 310 German Caucasian ovarian cancer patients and 364 healthy controls. We also typed 124 affected and 276 unaffected female carriers w...
Autores principales: | Wang-Gohrke, S, Weikel, W, Risch, H, Vesprini, D, Abrahamson, J, Lerman, C, Godwin, A, Moslehi, R, Olipade, O, Brunet, J-S, Stickeler, E, Kieback, D G, Kreienberg, R, Weber, B, Narod, S A, Runnebaum, I B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374363/ https://www.ncbi.nlm.nih.gov/pubmed/10487631 http://dx.doi.org/10.1038/sj.bjc.6690669 |
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma.
por: Runnebaum, I. B., et al.
Publicado: (1996) -
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022) -
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011) -
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010)